Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Reports outline cancer vaccines research from University of Toronto
August 6th, 2008
"Reports of turner regression after infection date back as far as 1550 BC. In the twentieth century, Dr," scientists writing in the Journal of Thoracic Oncology report. "William Coley, witnessing regression of a malignant tumor in one of his patients after a bacterial infection, developed the first cancer treatment vaccine derived from killed bacteria, with some reported success. However, despite decades of research, no specific, active tumor vaccine has been approved for the treatment of cancer. In lung cancer, initial attempts to modulate the immune system with nonspecific therapies were unsuccessful. However, more sophisticated specific vaccines have now been...
Source: Vaccine Weekly (2008-08-06)
|
